increase font size
Foot and Mouth disease can have a devastating effect - the UK’s 2000 outbreak saw the compulsory slaughter of over six million animals.
Foot and Mouth Disease outbreaks could have a detrimental impact on any country's rural sector, as seen in the United Kingdom's 2000 outbreak that saw the compulsory slaughter of over six million animals.
Closer to home, the disease is widespread in parts of Indonesia.
International collaboration between US company Tibia BioTech and the New South Wales (NSW) government means Australia is poised to begin producing the first mRNA vaccine against FMD domestically, aimed at keeping the country safe from the ravages of an outbreak.
The vaccine, successfully tested at the German Friedrich-Loeffler-Institut (FLI) in large animals, also offers short production timeframes, meaning response time to outbreaks is slashed.
Traditional FMD vaccines involve using large quantities of the virus cultivated under strict safety conditions, whereas mRNA vaccines can be produced without this process. The mRNA vaccine is fully synthetic and said to be safer and much faster to produce without the need to use infectious material. According to FLI, mRNA vaccines can be produced without any special biosafety requirements.
The vaccine was developed by Tiba scientists as part of an international research collaboration with the Elizabeth Macarthur Agricultural Institute and the RNA Institute at the University of New South Wales, with support from the NSW Department of Primary Industries and Regional Development and Meat & Livestock Australia.
This success builds on earlier livestock vaccine research supported by the Bill and Melinda Gates Foundation and Canada's International Development Research Centre.
"With this new development, Australia is now one of only a small number of countries with local capacity to produce a foot and mouth disease (FMD) vaccine," said Tara Moriarty, Minister for Agriculture, Regional and Western NSW.
"Developing local manufacturing capacity to produce vaccines against emergency animal diseases is a critical priority so we can protect Australia's livestock industries, our economy and our food supply.
To vaccinate vulnerable cattle, it has been suggested it might require up to one million doses in a region, so currently there is a need to scale up the vaccine and accelerate its journey from the lab to local mass scale production. However, before it can be made available and scaled for markets, the vaccine needs to show that it meets Australian Pesticides and Veterinary Medicines Authority standards.
The FLI has said that studies are also needed to determine whether adequate protection can be achieved with a single dose of the vaccine, and how quickly that protection develops after vaccination. Further information notes that the vaccine can be stored long-term at standard refrigeration temperatures, or at room temperature for at least 1 month - a critical advantage in livestock applications.
Although Australia has been FMD-free since 1872, the Australian Bureau of Agricultural and Resource Economics and Sciences estimates the impact of a widespread incursion of FMD could cost AU$80 billion to Australia's livestock industry over a 10-year period. Australia's national science agency CSIRO says the disease is still considered the most serious biosecurity threat to Australia's livestock industries.
OPINION: It's no surprise that "world-class biosecurity" continues to dominate as the top priority for agribusiness leaders, holding the number one spot for the 16th consecutive year in KPMG's latest agribusiness report.
Six industry organisations, including DairyNZ and the Dairy Companies Association (DCANZ) have signed an agreement with the Ministry for Primary Industries (MPI) to prepare the country for a potential foot and mouth outbreak.
Six livestock industry groups have signed a new agreement with the Government on how to prepare for, and respond to, a possible outbreak of Foot and Mouth Disease.
Sheep and beef farmers have voted to approve Beef + Lamb New Zealand signing an operational agreement between the agricultural sector and the Government on foot and mouth disease readiness and response.
Biosecurity Minister Andrew Hoggard says that events over the last few weeks have highlighted the importance of a strong biosecurity system.
LIC shareholders have elected a new North Island representative to the co-operative's Board, along with five representatives to its Shareholder Reference Group (SRG), following the company's Annual Meeting held in Invercargill.
Farmers across parts of Southland and South Otago are continuing to deal with difficult conditions after a prolonged run of wet weather, with pressure building around feed supply, stock management, pasture damage, farm infrastructure and everyday workloads.
Federated Farmers says it welcomes Labour's commitment to reviewing the Sharemilking Agreements Act, calling on other major parties to do the same.
For Canterbury dairy farmers Sian Meijer and Rick Wobben, wearable technology has become one of their most valuable on-farm tools - helping manage 1850 cows across an expansive, high-performing dairy operation while improving efficiency, mating outcomes and day-to-day decision making.
Fonterra has unveiled its annual results for the 2026 financial year, posting $27 billion in revenue and close to $20 billion returned to New Zealand farmer owners and unit holders.
The first major update to the Dairy Cattle Code of Welfare in more than a decade has been released, marking what DairyNZ describes as an important step in ensuring animal welfare standards continue to evolve alongside scientific evidence and on-farm realities.
OPINION: It seems Canterbury processor Synlait is still in the doldrums.
OPINION: Get offside with New Zealand First leader Winston Peters at your own peril.
